Susceptibility of colorectal cancer cells to Sindbis virus infection

Chao Li1, Youling Gu, Dario Andrade

  • 1Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73190, USA.

Insights

Sindbis virus (SIN) shows promise as an anti-tumor agent, selectively infecting colorectal cancer cells. This virus preferentially targets aggressive and metastatic cancer cells, suggesting a novel infection mechanism.

Area of Science:

  • Virology
  • Oncology
  • Cancer Biology

Background:

  • Sindbis virus (SIN), a Togaviridae family member, is an effective anti-tumor agent with variable infection efficiency across cell types.
  • Understanding SIN's tropism is crucial for optimizing its oncolytic potential.

Purpose of the Study:

  • To compare SIN infection efficiency in colorectal cancer cells versus other cancer types.
  • To investigate the correlation between SIN susceptibility and colorectal cancer cell metastatic potential.

Main Methods:

  • Infection assays were performed on ten colorectal cancer cell lines and cell lines from breast, leukemia, and prostate cancers.
  • A mouse xenograft model was used to assess SIN targeting of metastatic colon cancer cells.
  • Viral attachment and entry mechanisms were analyzed, including 67kD laminin receptor expression.

Main Results:

  • Nine out of ten colorectal cancer cell lines were sensitive to SIN infection, while breast, leukemia, and prostate cancer cells were largely resistant.
  • SIN susceptibility positively correlated with the metastatic potential of colorectal cancer cells, with SW620 and COLO-320DM showing highest sensitivity.
  • SIN preferentially targeted metastatic cells in vivo, independent of 67kD laminin receptor expression, indicating enhanced viral attachment and entry.

Conclusions:

  • Sindbis virus demonstrates selective tropism for colorectal cancer cells, particularly those with high metastatic potential.
  • The virus may utilize a novel mechanism for cell attachment and entry, distinct from the 67kD laminin receptor.
  • These findings support SIN's potential as a targeted oncolytic virotherapy for colorectal cancer.